Omicron Pharma
  • Home
  • Products
    • Women’s Health
      • Women Infertility
      • Pregnancy
      • Bone Health
      • Anemia
      • Vaginal Health
    • Men’s Health
      • Male Infertility
    • Cardiovascular Health
    • Weight Management
      • Weight Reduction
      • Reshaping
      • Appetite Control
    • Skin Health
      • Wounds & Burns
    • Pediatric Health
    • Respiratory Health
  • Literature
  • Careers
  • About us
  • Contact us
Select Page
Vitamin K2 supplementation and arterial stiffness among renal transplant recipients—a single-arm, single-center clinical trial

Vitamin K2 supplementation and arterial stiffness among renal transplant recipients—a single-arm, single-center clinical trial

Subclinical vitamin K deficiency is prevalent among renal transplant recipients and is associated with an increased risk of cardiovascular disease. However, the association between vitamin K supplementation and improvement of arterial stiffness has not been explored...
High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial

High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial

Background: Vascular calcifications are highly prevalent in hemodialysis patients. Dephosphorylated-uncarboxylated MGP (dp-ucMGP) was found to increase in vitamin K-deficient patients and may be associated with vascular calcifications. Supplementation of hemodialysis...
Next Entries »

Recent Posts

  • Cold & Cough®
  • Chewie Bone®
  • Hyperoil®
  • Lypotrol®
  • Cenitrol®

Recent Comments

  1. A WordPress Commenter on High Dephosphorylated-Uncarboxylated MGP in Hemodialysis patients: risk factors and response to vitamin K2, A pre-post intervention clinical trial


Phone

+961 5 922 831



Email

info@omicron-pharma.com

Subscribe For Updates

Success!

Subscribe

  • Follow
  • Follow
  • Follow